Good access to care and contraception support SDG 3.

This supports SDGs 3 and 5 by supporting access to care and contraception.

This article ties to SDG 3. In this study, the longitudinal association between a measure of how people cope with uncertainty (intolerance of uncertainty (IU)), fears for the future, posttraumatic stress disorder (PTSD) symptoms and depression symptoms was investigated.

This article ties to SDG 3. This study aimed to identify assessment and referral practices of emergency departments at rural community hospitals related to care for suicidal veterans and explore the feasibility and acceptability of identifying veterans in need of postdischarge aftercare.

This Article supports SDG 3 by describing a cost-effectiveness analysis of point-of-care HCV testing compared with standard of care (laboratory-based testing) in particular settings with people at risk of HCV infection (prisons, needle and syringe programme, drug treatment clinics). It found that all point-of-care testing strategies assessed had a lower cost per treatment initiation than standard of care regardless of setting of HCV antibody prevalence.

This article aligns with the SDG goal 3 of Good health and wellbeing and SDG 10 Reduced inequalities by evidencing that the magnitude of hepatitis delta virus (HDV) infection increases with the severity of liver disease among chronic hepatitis B patients in Ethiopia.

This Article supports SDG 3 by estimating the disease burden and establishing a baseline of linkage to care for hepatitis B virus in Ho Chi Minh City, Vietnam, showing the feasibility of a large-scale comprehensive screening and access-to-care program for hepatitis B virus elimination in a low-to middle-income country.

Alzheimer's disease (AD) is a severe global public health issue because it is an irreversible neurodegeneration of the brain that impairs personality, cognition, memory, and other functions before it ultimately results in death from total brain failure.

The most prevalent type of neurogenerative condition linked to dementia, based on the current situation, is Alzheimer's Disease (AD).

Medications used in the treatment of Alzheimer's disease include the acetylcholinesterase inhibitors (AChEIs, i.e., donepezil, rivastigmine, and galantamine), the N-methyl-D-aspartate receptor (NDMAR) antagonist, memantine, and the anti-amyloid beta monoclonal antibody, aducanumab.